Platelet Aggregation Devices Market is estimated to reach USD 725.8 Million by 2028 from USD 501.1 Million in 2021, growing at a CAGR of 6.5% between2022 and 2028. Platelets are a type of blood cell that is responsible for the density of blood in the body. The accumulation of platelets in the blood is known as platelet aggregation. It is part of a series of events that lead to the formation of clots. Platelet Aggregation Devices assess the extent to which platelets interact.
Platelet aggregation testing involves venepuncture in a non-invasive environment, which is produced by the process of centrifugation plasma extraction. In this process, an aggregometer is used. The process of platelet aggregation involves a variety of medical tools that provide accurate control of active blood flow and thus control the rate of platelet thrombus formation. Factors such as increased awareness and acceptance of platelet-related treatments for diseases such as cancer, drive the market growth of Platelet Aggregation Devices. Technological advances in platelet aggregation also accelerate market growth. Increased demand for platelet testing programs in the diagnosis of diseases such as HIV and dengue has led to an increase in the market for platelet aggregation equipment. Increasing the number of collaborations between academic and industrial research on clinical studies increases the market for Platelet Aggregation Devices. Though, barriers such as the reduction of opportunities at the end-user level and the high costs associated with the purchase of devices reduce the market growth of devices that include platelets. Demand With a large amount of blood for blending method can reduce the use of platelet aggregation method that can affect the market.
Platelet Aggregation Devices include devices such as platelet function analyzer (PFA), aggregometer, platelet aggregation systems, and centrifuge operating platelets. On a product basis, the global Platelet Aggregation Devices Market is divided into three main categories, namely, tools, reagents, and consumables & accessories. Based on end-user experience, the global Platelet Aggregation Devices Market is divided into private hospitals, diagnostic laboratories, research and education centers, and other end users such as blood banks and pharmaceutical-biotechnology companies. The private hospital sector is expected to have the largest share in the global market. This is due to the benefits provided to hospitals by conducting a screening process to include platelet aggregation, a large number of patients with targeted diseases, investment growth of private companies to upgrade modern health care infrastructure, as well as an increasing number of hospitals in developing countries.
Geographically, the market for Platelet Aggregation Devices is divided into five regions, namely, North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The Asia Pacific Platelet Aggregation Devices Market is poised to grow at the highest CAGR due to factors such as the high number of patients with targeted diseases, the strong presence of equipment manufacturers in the region, growing number of surgeries, annual processes, growing awareness among health care professionals, and the availability of significant funding to support platelet-based R&D programs.
The introduction of new products and product development are key strategies adopted by major players to improve their position in the globalPlatelet Aggregation Devices Market. Major companies in the Platelet Aggregation Devices Market are Bio/Data Corporation (US), Helena Laboratories Corporation (US), WerfenLife (Spain),F.Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany)..